Document Detail


Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma.
MedLine Citation:
PMID:  20440753     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most difficult cancers to treat. The interleukin (IL)-12 family cytokines, including IL-12, IL-23 and IL-27, display overlapping, but not redundant, roles in regulating lymphocyte subpopulations. IL-12 is known as a potent antitumor cytokine, whereas the results of the antitumor effect of IL-23 and IL-27 are inconsistent. The present study aimed to directly compare the relative antitumor efficacy of these three IL-12 family cytokines on HCC.
METHODS: A murine orthotopic BNL HCC model, in which the tumor is located in an environment heavily populated with different lymphocyte subsets, was established. The hepatotropic adeno-associated virus serotype 8 (AAV8) vector was used to deliver the cytokine genes aiming to achieve sustained cytokine expression in the liver.
RESULTS: AAV8/IL-12 treatment significantly reduced hepatic metastases and prolonged survival time, whereas treatment with AAV8/IL-23 or AAV8/IL-27 had only moderate antitumor effects at a high dose. The antitumor efficacy of these cytokines was positively correlated with their ability to regulate hepatic T cells, natural killer cells and natural killer T cells, with IL-12 greatly increasing the number and activation status of these cells, whereas IL-27 had no effect and IL-23 had a negative effect. AAV8/IL-12 treatment also resulted in a marked decrease in tumor vessel density, which was not observed with AAV8/IL-23 and AAV8/IL-27 treatment.
CONCLUSIONS: The data obtained in the present study highlight the importance of local lymphocytes and anti-angiogenesis for influencing the antitumor activity of these three IL-12 family cytokines and suggest that IL-12 is the best candidate for treating HCC.
Authors:
Chia-Hui Lo; Chia-Ming Chang; Shih-Wen Tang; Wen-Yu Pan; Cheng-Chieh Fang; Yin Chen; Ping-Yi Wu; Kai-Yun Chen; Hsin-I Ma; Xiao Xiao; Mi-Hua Tao
Related Documents :
8648753 - Induction of interleukin-12 (il-12) by recombinant glycoprotein gp120 of human immunode...
20739833 - Toll-like receptor 9-mediated inhibition of apoptosis occurs through suppression of fox...
15199963 - The lectin-complement pathway--its role in innate immunity and evolution.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The journal of gene medicine     Volume:  12     ISSN:  1521-2254     ISO Abbreviation:  J Gene Med     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815764     Medline TA:  J Gene Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  423-34     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 John Wiley & Sons, Ltd.
Affiliation:
Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combining keratinocyte growth factor transfection into the airways and tracheal occlusion in a fetal...
Next Document:  Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazin...